Product Information
XIIDRA 5% EYE DROPS is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.8317 per EA under NDC 00078091112. Its NADAC has been published 294 times since Nov 11, 2020.
Strength
50 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078091112
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
LIFITEGRASTApproval Type
New Drug (NDA)
FDA Application
NDA208073On Market Since
7/11/2016
Pharmacological Classes
Price Statistics
The NADAC for XIIDRA 5% EYE DROPS has been published 294 times since Nov 11, 2020, and over the history we have for it it has risen 33.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8317 per EA |
|---|---|
| All-time high | $11.8386 (May 13, 2026) |
| All-time low | $8.8473 (Dec 23, 2020) |
| 52-week high | $11.8386 |
| 52-week low | $11.4891 |
| Median price | $10.9471 |
| Average price | $10.7020 |
| Largest weekly change | +8.0% (Jan 11, 2023) |
| Weeks tracked | 294 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of XIIDRA 5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for XIIDRA 5% EYE DROPS, manufactured by Novartis Pharmaceuticals Corporation, is $11.8317 per EA (NDC 00078091112), effective Jun 24, 2026.
How has the price of XIIDRA 5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for XIIDRA 5% EYE DROPS has risen 33.5%. It has been tracked across 294 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for XIIDRA 5% EYE DROPS?
Since Nov 11, 2020, the NADAC for XIIDRA 5% EYE DROPS has ranged from a low of $8.8473 (Dec 23, 2020) to a high of $11.8386 (May 13, 2026), with a median of $10.9471 per EA.
Are there cheaper alternatives to XIIDRA 5% EYE DROPS?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as XIIDRA 5% EYE DROPS, but none are currently priced below it.
Who manufactures XIIDRA 5% EYE DROPS?
XIIDRA 5% EYE DROPS (NDC 00078091112) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification